Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Director/PDMR Shareholding

12 Jul 2012 07:38

RNS Number : 5028H
BrainJuicer Group PLC
12 July 2012
 



 

 

 

Press Release

12 July 2012

 

 

BrainJuicer Group PLC (AIM: BJU)

 ("BrainJuicer" and the "Company")

 

Director Dealing

 

BrainJuicer, a leading international online market research agency, today announces that on 11 July it was notified that, given the level of demand in the Company's shares, John Kearon, the Company's Chief Executive Officer, sold 15,000 ordinary shares (c. 0.4% of his total holding) in the Company at a price of 326.5 pence per ordinary share on 11 July. Following the above transaction, he holds 3,846,102 shares (30.7% of the Company's issued share capital with voting rights).

 

 

- Ends -

 

 

 

For further information, please contact:

BrainJuicer Group PLC

John Kearon, Chief Executive Officer

Tel: +44 (0)20 7043 1000

James Geddes, Chief Financial Officer

www.brainjuicer.com

 

Canaccord Genuity Limited

Simon Bridges / Henry Fitzgerald-O'Connor

Tel: +44 (0)20 7 523 8000

www.canaccordgenuity.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSFDSMEFESEDW
Date   Source Headline
5th Jun 20077:03 amRNSProgress - Predictive Markets
25th May 200712:45 pmRNSResult of AGM
30th Apr 20077:01 amRNSTotal Voting Rights
25th Apr 20075:41 pmRNSIssue of Equity
12th Apr 20077:01 amRNSPreliminary Results
5th Apr 20077:01 amRNSNotice of Results
19th Jan 20075:10 pmRNSDirector/PDMR Shareholding
15th Dec 200611:13 amRNSTotal Voting Rights
5th Dec 20068:00 amRNSFirst Day of Dealings on AiM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.